Zhitong Finance App News, Shiyao Group (01093.HK) issued an announcement. The Group announced the data of the Phase I clinical study of SYS6002 monotherapy for the treatment of advanced cervical cancer (this study) in the form of a quick oral report at the 2026 International Society of Gynecological Oncology Global Annual Meeting (IGCS 2026).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.